Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
Report Scope:
Chronic disease management includes numerous drugs and medical device-based techniques used for the management of various chronic diseases. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for chronic disease management through various therapeutics and advanced device technologies.
The current report will provide detailed exposure to chronic disease management market. This report analyzes the market trends of chronic disease management with data from 2020, estimates from 2021, projections of compound annual growth rates through 2026 (forecast period 2021 – 2026), and regional markets of the chronic disease management. This report will highlight the current and future market potential of chronic disease management along with a detailed analysis of the competitive environment. Regulatory scenario, drivers, restrains, and opportunities will be covered in the current report. The report also covers market projections for 2026, and market Shares of key market players.
The market has been segmented based on product segment, segment, disease type, treatment provider, and geography. Based on product segment, the market in this report is segmented into pharmaceutical drugs & biologics (drugs and biologics) and medical device technologies and applications (traditional devices and wearable devices and applications). On the basis of disease type the market is segmented into cancer, diabetes, musculoskeletal, cardiovascular, HIV and related conditions, gastro-intestinal, respiratory, neurology, psychiatry, and other disorders. Based on the treatment adherence, the market in this report is segmented into treatment adherence systems and treatment adherence applications (cloud-based). By delivery technology the chronic disease management market is segmented into injectable and parenteral delivery, oral delivery, nasal & pulmonary, transdermal and others. On the basis of treatment provider, the market is segmented into hospitals & others and home care.
The regional market analysis of chronic disease management is also covered in this report. The market has been segmented into various major regions including North America, Europe, Asia-Pacific, and rest of world regions. Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India are going to be covered within the regional segment. For market estimates, data are going to be provided for 2020 because the base year, with estimates for 2021 and forecast value for 2026.
Report Includes:
- 99 data tables
- An up-to-date review and analysis of the global market for chronic disease management therapeutics and device technologies
- Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the overall market size, forecasted growth trends, and corresponding market share analysis by product category, disease type, delivery technology, treatment adherence, treatment provider, and region
- Insight into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support effective disease state management
- Regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the market
- Key merger and acquisition deals, development of commercially viable products and technologies, and other strategic alliances within the industry
- Profile descriptions of the leading global players including Abbott, AbbVie Inc., Amgen Inc., Bayer AG, Boston Scientific Corp., Dr. Reddy’s Laboratories Ltd., F. Hoffmann, GlaxoSmithKline PLC, Johnson & Johnson, Medtronic, Novartis, Sanofi, Pfizer and Takeda
Companies Mentioned
ABBOTT
ABBVIE INC.
ACADIA PHARMACEUTICAL
ACORDA THERAPEUTICS
ADHERIUM
AGENUS
AKRON
ALIVECOR
ALKERMES
AMGEN INC.
AMIKO
AMNEAL PHARMACEUTICALS
ANAVEX LIFE SCIENCES
ANI PHARMACEUTICALS
APOTEX
ARENA PHARMACEUTICALS
ASAHI KASAI CORP.
ASLAN PHARMACEUTICALS
ASPEN PHARMACARE
ASTELLAS PHARMA INC.
ASTRAZENECA
ATHERSYS
AXSOME THERAPEUTICS
Bausch Health Companies Inc.
BAYER AG
BEIGENE
BIOSENSICS
BIOSERENITY
BIOTRICITY
BIOTRONIK
BIOXCEL THERAPEUTICS
Boehringer Ingelheim International GmbH
BOSTON SCIENTIFIC CORPORATION
BRISTOL-MYERS SQUIBB
BTS BIOENGINEERING
CHUGAI PHARMACEUTICALS CO., LTD.
CIPLA
CLOVIS ONCOLOGY
CONNECTEDHEALTH PTE. LTD.
CORBUS PHARMACEUTICALS
CSPC PHARMACEUTICAL GROUP
DAIICHI SANKYO
DR. REDDY’S LABORATORIES LTD.
EARLYSENSE
EDWARDS LIFESCIENCES CORP.
ELI LILLY
EMPATICA
ENDO INTERNATIONAL
ENDOCEUTICS INC.
ERYTECH PHARMA
ESTEVE
EVERIST HEALTH
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
GLAXOSMITHKLINE PLC
GLOOKO INC.
HALOZYME THERAPEUTICS
HIKMA PHARMACEUTICALS
HOCOMA
IHEALTH
INFOBIONIC INC.
INSULET CORP.
INTELESENS
INTRA-CELLULAR THERAPIES
IOVANCE BIOTHERAPEUTICS
IPSEN S.A.
JAN MEDICAL INC.
JIANGSU HENGRUI MEDICINE
JOHNSON & JOHNSON SERVICES INC.
KYOWA HAKKO KIRIN
LES LABORATOIRES SERVIER
LUNDBECK
LUPIN
MALLINCKRODT PLC
MEDMINDER
MEDTRONIC INC.
MENARINI
MERCK KGAA
MITSUBISHI TANABE PHARMA
NEMAURA MEDICAL INC.
NEOFECT CO., LTD.
NEUROCRINE BIOSCIENCES
NEUROMETRIX INC.
NOVARTIS AG
NOVO NORDISK
NUCANA
OMADA HEALTH INC.
OMNICELL INC.
OMRON CORP.
ONO PHARMACEUTICAL CO., LTD.
ORION PHARMA LTD.
OTSUKA HOLDINGS CO., LTD.
PACIRA PHARMACEUTICALS INC.
PFIZER INC.
PHILOSYS
POLAR ELECTRO OY
PRESCRIBEWELLNESS LLC
PREVENTICE INC.
PROPELLER HEALTH
QARDIO
REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
SAGE THERAPEUTICS
SANOFI S.A.
SAREPTA THERAPEUTICS
SENSE4CARE
SHANGHAI PHARMACEUTICALS HOLDING
SHIONOGI AND CO., LTD.
STADA ARZNEIMITTEL AG
SUMITOMO DAINIPPON PHARMA CO., LTD.
SUN PHARMACEUTICAL INDUSTRIES
TAISHO PHARMACEUTICAL
TAKEDA PHARMACEUTICAL COMPANY LTD.
TCR2 THERAPEUTICS
TEVA PHARMACEUTICALS INDUSTRIES LTD.
TYME TECHNOLOGIES
VERTEX PHARMACEUTICAL
VIATRIS INC.
VITAL CONNECT
WEST PHARMACEUTICAL SERVICES INC.
WINMEDICAL SRL
YPSOMED HOLDING AG
ZOGENIX INC.
ZYDUS CADILA
- Chapter 1 Introduction
- Study Goals and Objectives
- What’s New in the Report?
- Reasons for Doing This Study
- Scope of Report
- Information Sources
- Methodology
- Geographic Breakdown
- Analyst’s Credentials
- BCC Custom Research
- Related BCC Research Reports
- Chapter 2 Summary and Highlights
- Chapter 3 Chronic Diseases and Growing Burden on Economy
- Background of Chronic Diseases
- Epidemiology and Global Burden
- Chronic Disease Types
- Cardiovascular Disease
- Lifestyle Disorders
- Cancer
- Respiratory Disorders
- Musculoskeletal Disorders
- Mental/Mood Disorders
- Gastro-intestinal Disorders
- Immune Disorders
- Neurological Disorders
- Other Chronic Disorders
- Tobacco Smoking and Chronic Diseases
- Aging, Gender and Chronic Diseases
- Global Demographics
- U.S. Demographics
- U.S: Gender, Age and Life Expectancy
- European Demographics
- Japanese Demographics
- Current Challenges and Future Directions
- Chapter 4 Impact of COVID-19
- Overview
- COVID-19 Crisis
- Impact on Market for Chronic Diseases Management
- Current Outlook
- Chapter 5 Chronic Diseases: Therapeutics
- Therapeutics and Chronic Diseases
- Generic Drugs and Chronic Diseases
- Generic Drugs vs. Branded Drugs
- Continued Resistance for Generics
- Biologics and Biosimilars for Immune-Mediated Chronic Diseases
- Cancer and Targeted Therapy
- Clinical Need for Therapeutics
- Therapeutics and Cost Burden
- Chronic Diseases and Managed Care
- Key Marketed and Pipeline Products
- Key Marketed Products
- Key Pipeline/R&D Products
- Unmet Need
- Current Challenges and Future Developments
- Chapter 6 Device Technologies and Applications
- Medical Devices and Chronic Disease Management
- Clinical and Market Need of Digital Therapeutics
- Types of Device Technologies
- Diagnostic and Monitoring Devices
- Therapeutic Devices and Technologies
- Key Marketed and R&D/Pipeline Products
- Diagnostic and Monitoring Devices
- Therapeutic Devices and Technologies
- Advantages of Chronic Disease Management via Digital Care
- Unmet Need
- Future Developments for Healthcare and Safety Monitoring
- Current Challenges
- Future Outlook
- Chapter 7 Chronic Diseases: Treatment Adherence Devices and Applications
- Treatment Nonadherence
- Market Need for Medication Adherence Systems and Applications
- Types of Medication Adherence Systems and Applications
- Hardware-Centric Medication Adherence Systems
- Medication Adherence Software Applications
- Key Marketed and Pipeline Products
- Hardware-Centric Medication Adherence Systems
- Medication Adherence Software Applications
- Software and Mobile Application Advantages
- Interconnectivity of Adherence App
- Effectiveness of Smartphone Adherence Apps
- Current Challenges
- Future Developments
- Chapter 8 Market Size and Growth Analysis
- Market Size and Growth Analysis
- Market Size and Growth Analysis by Region
- Market Size and Growth Analysis by Product Segment
- Market Size and Growth Analysis by Chronic Disease Type
- Market Size and Growth Analysis by Treatment Provider and Target Health Settings
- Market Growth Drivers and Restraints
- Market Growth Drivers
- Market Restraints
- Chapter 9 Competitive Landscape
- Chapter 10 Strategies in the Market for Chronic Disease Management
- Consolidations
- Mergers and Acquisitions
- Recent Mergers and Acquisitions
- Acquisitions in the Therapeutics (Drugs and Biologics) Space
- Minority Stakes and Future Options to Acquire
- Future Strategic Landscape
- Chapter 11 Regulatory Structure: Pharmaceuticals and Medical Devices
- Regulatory Background
- Regulatory Systems for Medical Devices by Region
- U.S.
- European Union
- Japan
- Regulatory Systems for Pharmaceuticals by Region
- U.S.
- Europe
- Japan
- Chapter 12 Pricing and Reimbursement: Pharmaceuticals and Medical Devices
- Pricing and Reimbursement Background
- Pricing and Reimbursement for Medical Devices by Region
- U.S.
- Europe
- Japan
- Other Asia-Pacific
- Pricing and Reimbursement for Pharmaceuticals by Region
- U.S.
- Europe
- Japan
- Chapter 13 Conclusions—Outlook for Chronic Disease Management
- Major Developments Influencing the Market
- Technological Developments
- Demographic and Economic Trends
- Changing Structure of the Healthcare Industry
- Lifestyle Medicine
- Patient-Centric Programs
- Long-Term Outlook for Chronic Disease Management
- Chapter 14 Company Profiles
- Top 25 Major Companies
- ABBOTT
- ABBVIE INC.
- AMGEN INC.
- ASTELLAS PHARMA INC.
- ASTRAZENECA
- BAUSCH HEALTH COMPANIES INC.
- BAYER AG
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- BOSTON SCIENTIFIC CORPORATION
- BRISTOL-MYERS SQUIBB
- DR. REDDY’S LABORATORIES LTD.
- F. HOFFMANN-LA ROCHE LTD.
- GILEAD SCIENCES INC.
- GLAXOSMITHKLINE PLC
- JOHNSON & JOHNSON SERVICES INC.
- LUPIN
- MEDTRONIC INC.
- MERCK KGAA
- NOVARTIS AG
- OTSUKA HOLDINGS CO., LTD.
- PFIZER INC.
- SANOFI S.A.
- TAKEDA PHARMACEUTICAL COMPANY LTD.
- TEVA PHARMACEUTICALS INDUSTRIES LTD.
- VIATRIS INC.
- Other Players
- ACADIA PHARMACEUTICAL
- ACORDA THERAPEUTICS
- AGENUS
- ADHERIUM
- AKRON
- ALIVECOR
- AMIKO
- ANI PHARMACEUTICALS
- ALKERMES
- AMNEAL PHARMACEUTICALS
- ANAVEX LIFE SCIENCES
- APOTEX
- ARENA PHARMACEUTICALS
- ASLAN PHARMACEUTICALS
- ASAHI KASAI CORP.
- ASPEN PHARMACARE
- ATHERSYS
- AXSOME THERAPEUTICS
- BEIGENE
- BIOXCEL THERAPEUTICS
- BIOSENSICS
- BIOSERENITY
- BIOTRONIK
- BIOTRICITY
- BTS BIOENGINEERING
- CHUGAI PHARMACEUTICALS CO., LTD.
- CIPLA
- CLOVIS ONCOLOGY
- CONNECTEDHEALTH PTE. LTD.
- CORBUS PHARMACEUTICALS
- CSPC PHARMACEUTICAL GROUP
- DAIICHI SANKYO
- EARLYSENSE
- EDWARDS LIFESCIENCES CORP.
- ELI LILLY
- EMPATICA
- ENDO INTERNATIONAL
- ENDOCEUTICS INC.
- ERYTECH PHARMA
- ESTEVE
- EVERIST HEALTH
- GLOOKO INC.
- HALOZYME THERAPEUTICS
- HIKMA PHARMACEUTICALS
- HOCOMA
- IHEALTH
- INFOBIONIC INC.
- INSULET CORP.
- INTELESENS
- INTRA-CELLULAR THERAPIES
- IOVANCE BIOTHERAPEUTICS
- IPSEN S.A.
- JAN MEDICAL INC.
- JIANGSU HENGRUI MEDICINE
- LUNDBECK
- KYOWA HAKKO KIRIN
- LES LABORATOIRES SERVIER
- MALLINCKRODT PLC
- MEDMINDER
- MENARINI
- MITSUBISHI TANABE PHARMA
- NEMAURA MEDICAL INC.
- NEOFECT CO., LTD.
- NEUROCRINE BIOSCIENCES
- NEUROMETRIX INC.
- NOVO NORDISK
- NUCANA
- OMADA HEALTH INC.
- OMRON CORP.
- OMNICELL INC.
- ONO PHARMACEUTICAL CO., LTD.
- ORION PHARMA LTD.
- PACIRA PHARMACEUTICALS INC.
- PHILOSYS
- POLAR ELECTRO OY
- PREVENTICE INC.
- PRESCRIBEWELLNESS LLC
- PROPELLER HEALTH
- QARDIO
- REHAB-ROBOTICS (A MEMBER OF VINCENT MEDICAL HOLDINGS)
- SAGE THERAPEUTICS
- SAREPTA THERAPEUTICS
- SENSE4CARE
- SHANGHAI PHARMACEUTICALS HOLDING
- SHIONOGI AND CO., LTD.
- STADA ARZNEIMITTEL AG
- SUMITOMO DAINIPPON PHARMA CO., LTD.
- SUN PHARMACEUTICAL INDUSTRIES
- TAISHO PHARMACEUTICAL
- TCR2 THERAPEUTICS
- TYME TECHNOLOGIES
- VERTEX PHARMACEUTICAL
- VITAL CONNECT
- WEST PHARMACEUTICAL SERVICES INC.
- WINMEDICAL SRL
- YPSOMED HOLDING AG
- ZOGENIX INC.
- ZYDUS CADILA
- Chapter 15 Appendix A: List of Acronyms
- Chapter 16 Appendix B: Professional Organizations
- American Heart Association
- American Diabetes Association
- American Lung Association
- Infectious Diseases Society of America (IDSA)
- National Foundation for Infectious Diseases
- Center for Drug Evaluation and Research (CDER)
- Center for Devices and Radiological Health (CDRH)
- Centers for Medicare and Medicaid Services (CMS)
- European Databank for Medical Devices (EUDAMED)
- Food and Drug Administration (FDA or USFDA)
- Hormone Foundation
- International Diabetes Federation (IDF)
- International Federation of Pharmaceutical Manufacturers and Associations (IFPMA)
- Network for Excellence in Health Innovation (NEHI)
- National Center for Biotechnology Information (NCBI)
- National Institute of Aging (NIA)
- Pharmaceuticals and Medical Devices Agency (PMDA)
- World Cancer Research Fund International
- World Health Organization (WHO)
- List of Tables
- Summary Table : Overall Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, Through 2026
- Table 1 : Global Death Share, by Various Chronic Disease Types, 2018
- Table 2 : Global DALYs Share, by Various Chronic Disease Types, 2018
- Table 3 : Global Incidence Share of Hypertension, by Patient Group Type, 2018
- Table 4 : Global Prevalence of Angina Pectoris and Stroke (Survivors), Through 2030
- Table 5 : Global Incidence and Prevalence of all Stroke Types, 2019
- Table 6 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
- Table 7 : Structural Heart Disease: Management Through Medication
- Table 8 : BMI Calculation
- Table 9 : BMI Categories Based on Increasing Health Risks
- Table 10 : Trends in Obesity Composition of the World’s Population, Through 2025
- Table 11 : U.S. Obesity and Severe Obesity vs. General Population, Through 2025
- Table 12 : Global Diabetes Types Share
- Table 13 : Global Prevalence of Diabetes, by Type, Through 2040
- Table 14 : Global Prevalence of Breast Cancer, by Country/Region, Through 2025
- Table 15 : Global Epidemiology of Colorectal Cancer, by Region, Through 2030
- Table 16 : Prevalence of Multiple Sclerosis by Region, 2013 and 2020
- Table 17 : Global Deaths, by Various Types of Cancer, Through 2030
- Table 18 : Estimated Global Death Share, by Various Cancer Types, 2021
- Table 19 : Global Prevalence of Symptomatic Key Musculoskeletal Disorders, Through 2025
- Table 20 : Global Deaths, by Various Musculoskeletal Disorders, Through 2030
- Table 21 : Global Deaths from Digestive Diseases, by Region, Through 2025
- Table 22 : Global HIV Epidemic, By Age Group, 2020
- Table 23 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
- Table 24 : World Population, by Selected Region, Through 2030
- Table 25 : U.S. Population Estimates and Projections, by Age Group, Through 2030
- Table 26 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
- Table 27 : European Population Estimates and Projections, by Age Group, Through 2030
- Table 28 : Japanese Population Estimates and Projections, by Age Group, Through 2030
- Table 29 : Key Marketed Respiratory Disorder Therapeutics
- Table 30 : Key Marketed Mood Disorder Therapeutics
- Table 31 : Key Marketed Musculoskeletal Disorder Therapeutics
- Table 32 : Key Marketed Neurovascular Disease Therapeutics
- Table 33 : Key Marketed Immune Disorder Therapeutics
- Table 34 : Key Marketed Diabetes Therapeutics
- Table 35 : Key Marketed Cardiovascular Disease Therapeutics
- Table 36 : Key Marketed GI Disorder Therapeutics
- Table 37 : Key Marketed Cancer Therapeutics
- Table 38 : Key Pipeline/R&D Products: Cancer Therapeutics
- Table 39 : Key Pipeline/R&D Products: Neurological Disorder Therapeutics
- Table 40 : Key Pipeline/R&D Products: Cardiovascular Disease Therapeutics
- Table 41 : Key Pipeline/R&D Products: GI Disorder Therapeutics
- Table 42 : Key Pipeline/R&D Products: Musculoskeletal Disorder Therapeutics
- Table 43 : Key Pipeline/R&D Products: Diabetes Therapeutics
- Table 44 : Key Pipeline/R&D Products: Mood Disorder Therapeutics
- Table 45 : Key Marketed and Pipeline/R&D Devices: Cardiac Monitoring Devices and Technologies
- Table 46 : Key Marketed and Pipeline/R&D Devices: Continuous Glucose Monitoring Devices and Technologies
- Table 47 : Key Marketed and Pipeline/R&D Devices: Sleep-Monitoring Devices and Technologies
- Table 48 : Key Marketed and Pipeline/R&D Devices: Vital Sign and Activity Monitoring Devices and Technologies
- Table 49 : Key Marketed and Pipeline/R&D Devices: Pain Management Devices and Technologies
- Table 50 : Key Marketed and Pipeline/R&D Devices: Drug Delivery Devices and Technologies
- Table 51 : Smart Pills for Patient Monitoring
- Table 52 : Smart Pills for Oral Drug Delivery
- Table 53 : Key Marketed and Pipeline/R&D Devices: Insulin delivery Devices and Technologies
- Table 54 : Global Medication Adherence Percentages, by Chronic Diseases
- Table 55 : Automated Medication Dispensing Cabinets
- Table 56 : Smart Pill Dispensers, Pillboxes and Organizers
- Table 57 : Medication Tracking Devices and Apps
- Table 58 : Pill Organizer and Reminder Systems
- Table 59 : Smart Pill Cap and Bottle Systems
- Table 60 : Other Medication Adherence Solutions
- Table 61 : Health and Medication Reminder Apps
- Table 62 : Personalized Medication Adherence and Text Messaging Apps
- Table 63 : Health and Medication Monitoring Apps
- Table 64 : Cloud-Based Adherence Solutions and Databases
- Table 65 : Health and Medication Adherence Apps
- Table 66 : Other Medication adherence Apps
- Table 67 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, Through 2026
- Table 68 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Product Segment, Through 2026
- Table 69 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Disease Type, Through 2026
- Table 70 : Global Diabetes Estimates and Projections, 2019-2045
- Table 71 : Key Strategic Deals in the Chronic Disease Management and Device Technology Market, 2012-2019
- Table 72 : Key Strategic Deals in Chronic Disease Management Therapeutics Market, 2016-2021
- Table 73 : Key Strategic Deals for Business Units, Minority Stakes and Future Options to Acquire in the Chronic Disease Management Market, 2016-2019
- Table 74 : Differences in Regulatory Approval in the U.S. and Europe
- Table 75 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
- Table 76 : Abbott: Key Developments
- Table 77 : AbbVie Inc.: Key Developments
- Table 78 : Amgen Inc.: Key Developments
- Table 79 : Astellas Pharma Inc.: Key Developments
- Table 80 : AstraZeneca PLC: Key Developments
- Table 81 : Bayer AG: Key Developments
- Table 82 : Boehringer Ingelheim: Key Developments
- Table 83 : Boston Scientific Corp.: Key Developments
- Table 84 : Bristol-Myers Squibb Company: Key Developments
- Table 85 : Dr. Reddy’s Laboratories Ltd.: Key Developments
- Table 86 : F. Hoffmann-La Roche Ltd: Key Developments
- Table 87 : Gilead Sciences Inc.: Key Developments
- Table 88 : Johnson & Johnson Services Inc.: Key Developments
- Table 89 : Lupin: Key Developments
- Table 90 : Medtronic: Key Developments
- Table 91 : Novartis AG: Key Developments
- Table 92 : Otsuka Holdings Co., Ltd.: Key Developments, 2020
- Table 93 : Pfizer Inc.: Key Developments
- Table 94 : Sanofi S.A.: Key Developments
- Table 95 : Takeda: Key Developments
- Table 96 : Teva: Key Developments
- Table 97 : Viatris: Key Developments
- Table 98 : List of Acronyms Used in Chronic Disease Management
- List of Figures
- Summary Figure : Overall Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, 2019-2026
- Figure 1 : Global Death Share, by Various Chronic Disease Types, 2018
- Figure 2 : Global DALYs Share, by Various Chronic Disease Types, 2018
- Figure 3 : Global Incidence of Hypertension, by Patient Group Type, 2018
- Figure 4 : Global Prevalence of Angina Pectoris and Stroke (Survivors), 2004-2030
- Figure 5 : Global Prevalence of Congestive Heart Failure and Stroke, 2004-2030
- Figure 6 : Trends in Obesity Composition of the World’s Population, 2012-2025
- Figure 7 : U.S. Obesity and Severe Obesity vs. General Population, 2018-2025
- Figure 8 : Global Diabetes Types Share
- Figure 9 : Global Prevalence of Diabetes, by Type, 2018-2040
- Figure 10 : Global Prevalence of Breast Cancer, by Region/Country, 2015-2025
- Figure 11 : Global Epidemiology of Colorectal Cancer, by Region, 2000-2030
- Figure 12 : Global Deaths, by Various Cancer Types, 2000-2030
- Figure 13 : Estimated Global Death Share, by Various Cancer Types, 2021
- Figure 14 : Global Prevalence of Symptomatic Key Musculoskeletal Disorders, by Region, 2018
- Figure 15 : Global Death Share, by Various Musculoskeletal Disorders, 2015
- Figure 16 : Global Deaths from Digestive Diseases, by Region, 2018-2025
- Figure 17 : Global Shares of Key Wound Types, 2020
- Figure 18 : Estimated World Population and Annual Growth, by Selected Age Group, 2000-2030
- Figure 19 : World Population, by Selected Region, 2000-2030
- Figure 20 : U.S. Population Estimates and Projections, by Age Group, 2000-2030
- Figure 21 : Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
- Figure 22 : European Population Estimates and Projections, by Age Group, 2000-2030
- Figure 23 : Japanese Population Estimates and Projections, by Age Group, 2000-2030
- Figure 24 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Region, 2019-2026
- Figure 25 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Product Segment, 2019-2026
- Figure 26 : Global Market Shares of Therapeutics, by Pharmaceutical Drug and Biologic, 2020
- Figure 27 : Global Market Shares of Therapeutics, by Delivery Technology, 2020
- Figure 28 : Global Market Shares of Device Technologies, by Device Type, 2020
- Figure 29 : Global Market for Chronic Disease Management Therapeutics and Device Technologies, by Disease Type, 2019-2026
- Figure 30 : Global Market Shares of Therapeutics and Device Technologies, by Treatment Provider and Target Health Settings, 2020
- Figure 31 : Global Market Shares of Chronic Disease Management Therapeutics, by Leading Company, 2020
- Figure 32 : Global Market Shares of Chronic Disease Management Device Technologies, by Leading Company, 2020
- Figure 33 : Trends in Per Capita Real Gross Domestic Product Growth, by Region, 2015-2018
- Figure 34 : Abbott: Annual Revenue, 2018-2020
- Figure 35 : Abbott: Revenue Share, by Business Segment, 2020
- Figure 36 : AbbVie Inc.: Annual Revenue, 2018-2020
- Figure 37 : Amgen Inc.: Annual Revenue, 2018-2020
- Figure 38 : Amgen Inc.: Revenue Shares, by Product Sales, 2020
- Figure 39 : Astellas Pharma Inc.: Annual Revenue, 2018-2020
- Figure 40 : Astellas Pharma Inc.: Revenue Shares, by Product Sales, 2020
- Figure 41 : AstraZeneca PLC: Annual Revenue, 2018-2020
- Figure 42 : AstraZeneca PLC: Revenue Share, by Therapy Areas, 2020
- Figure 43 : Bausch Health Companies Inc.: Annual Revenue, 2018-2020
- Figure 44 : Bausch Health Companies Inc.: Revenue Share, by Business Segment, 2020
- Figure 45 : Bayer AG: Annual Revenue, 2018-2020
- Figure 46 : Bayer AG: Revenue Share, by Business Segment, 2020
- Figure 47 : Boehringer Ingelheim: Annual Revenue, 2018-2020
- Figure 48 : Boehringer Ingelheim: Revenue Share, by Business Segment, 2020
- Figure 49 : Boston Scientific Corp.: Annual Revenue, 2018-2020
- Figure 50 : Boston Scientific Corp.: Revenue Share, by Business Segment, 2020
- Figure 51 : Bristol-Myers Squibb Co.: Annual Revenue, 2018-2020
- Figure 52 : Dr. Reddy’s Laboratories Ltd.: Annual Revenue, 2018-2020
- Figure 53 : Dr. Reddy’s Laboratories Ltd.: Revenue Share, by Business Segment, 2020
- Figure 54 : F. Hoffmann-La Roche Ltd: Annual Revenue, 2018-2020
- Figure 55 : F. Hoffmann-La Roche Ltd: Revenue Share, by Division, 2020
- Figure 56 : Gilead Sciences Inc.: Annual Revenue, 2018-2020
- Figure 57 : Gilead Sciences Inc.: Revenue Share, by Products Sales, 2020
- Figure 58 : GlaxoSmithKline PLC: Annual Revenue, 2018-2020
- Figure 59 : GlaxoSmithKline PLC: Revenue Share, by Business Segment, 2020
- Figure 60 : Johnson & Johnson Services Inc.: Annual Revenue, 2018-2020
- Figure 61 : Johnson & Johnson Services Inc.: Revenue Share, by Business Segment, 2020
- Figure 62 : Lupin: Annual Revenue, 2018-2020
- Figure 63 : Medtronic: Annual Revenue, 2018-2020
- Figure 64 : Medtronic: Revenue Share, by Business Segment, 2020
- Figure 65 : Merck KGaA: Annual Revenue, 2018-2020
- Figure 66 : Merck KGaA: Revenue Share, by Business Segment, 2020
- Figure 67 : Novartis AG: Annual Revenue, 2018-2020
- Figure 68 : Novartis AG: Revenue Share, by Division, 2020
- Figure 69 : Otsuka Holdings Co., Ltd.: Annual Revenue, 2018-2020
- Figure 70 : Otsuka Holdings Co., Ltd.: Revenue, by Segment, 2020
- Figure 71 : Pfizer Inc.: Annual Revenue, 2018-2020
- Figure 72 : Sanofi S.A.: Annual Revenue, 2018-2020
- Figure 73 : Sanofi S.A.: Revenue Share, by Business Unit, 2020
- Figure 74 : Takeda: Annual Revenue, 2018-2020
- Figure 75 : Takeda: Revenue Share, by Therapeutic Areas, 2020
- Figure 76 : Teva: Annual Revenue, 2018-2020
- Figure 77 : Viatris: Annual Revenue, 2018-2020
- Figure 78 : Viatris: Revenue Share, by Product Category, 2020
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook